SECOND-LINE THERAPY

Clinical trials for SECOND-LINE THERAPY explained in plain language.

Never miss a new study

Get alerted when new SECOND-LINE THERAPY trials appear

Sign up with your email to follow new studies for SECOND-LINE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for advanced stomach cancer: drug combo targets patients who failed first-line therapy

Disease control Recruiting now

This study tests a combination of two drugs, carilizumab and albumin paclitaxel, as a second treatment for people with advanced stomach cancer. It includes 40 adults aged 18-75 who have already tried one prior treatment, with or without immunotherapy. The goal is to see if this c…

Matched conditions: SECOND-LINE THERAPY

Phase: PHASE2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

SECOND-LINE THERAPY

Get alerted when new SECOND-LINE THERAPY trials appear

New hope for advanced stomach cancer: drug combo targets patients who failed first-line therapy